📈 Popular:

Broker of the month

Top 27 Regulated Forex Brokers

Forex No Deposit Bonuses

Promotions

⚡ Easily Trade – Apple, Microsoft , Tesla and Google Stocks – Open a FREE Account Here

Best Brokers

1st Place

2nd Place

3rd Place

4th Place

5th Place

GlaxoSmithKline Consumer Nigeria

Buy Glaxo Smithkline Consumer Nigeria stocks

GlaxoSmithKline Consumer Nigeria (NGX: GLAXOSMITH) Stocks

What is GlaxoSmithKline Consumer Nigeria Plc?

Glaxo Smithkline Consumer Nigeria Plc is a Nigerian-based company that traces its history to 1971 when it was incorporated. Glaxo Smithkline Consumer Nig. Plc is involved in research-based pharmaceuticals and healthcare.

The principal activities of Glaxo Smithkline Consumer Nig. Plc is spread across an extensive portfolio consisting of the manufacturing, marketing, and distribution of a wide range of consumer healthcare and pharmaceutical products.

Glaxo Smithkline Consumer Nigeria Plc’s main business segments are:

  • Consumer Healthcare includes over-the-counter (OTC) medicines, nutritional healthcare, and oral care.
  • Pharmaceuticals include antibacterial, vaccines, and prescription drugs.
  • Consumer Healthcare brands include Panadol, Andrews Liver Salt, MacLean’s, Otrivin, Sensodyne, Voltaren, and many others.
  • Global Manufacturing and Supply (GMS) which is the manufacturing unit of Glaxo Smithkline Consumer Nig. Plc based in Agbara, Ogun State.

 

Glaxo Smithkline Consumer Nig. Plc’s equity stocks are for sale online on the Nigerian Stock Exchange (NGX) under the stock symbol GLAXOSMITH. Today, Glaxo Smithkline Consumer Nig. Plc forms part of the Biotechnology and Drugs Industry, the Healthcare Sector, and Pharmaceuticals subsector.

 

GlaxoSmithKline Consumer Nigeria Plc Performance

The current share price for Glaxo Smithkline Consumer Nigeria Plc stocks is 6.50 NGN and the company has a total market capitalization of 7.77 billion NGN, with a P/E ratio of 11.21 NGN and earnings per share of 0.58 NGN, and a total of 1.2 billion shares outstanding.

In an analysis of financial data, Glaxo Smithkline Consumer Nigeria Plc showed that profits for the second quarter of 2022, which ended in June were 1,737 million NGN, up from the 1,037 million NGN reported for the end of March.

The operating income for the period that ended in June was 309.11 million NGN, showing significant improvements from the (242.12) million NGN reported for the previous quarter. Net income after taxes was 297.97 million NGN, with a diluted EPS excluding ExtraOrd items of 0.25 NGN and a diluted normalised EPS of 0.25 NGN.

The financial performance for Glaxo Smithkline Consumer Nig. Plc for the second quarter of 2022 showed significant improvements from the previous quarter, which means that those who want to buy or sell GLAXOSMITH stocks can expect lucrative dividends and returns.

According to an analysis on the live chart for GLAXOSMITH, analysts forecast that Glaxo Smithkline Consumer Nig. Plc will further improve its balance sheet in the following quarters, with strong finances reported during the last quarter, aided by the return to normal economic activities after several waves in the Covid-19 pandemic that crippled the global economy.

The share price of Glaxo Smithkline Consumer Nig. Plc has increased by 7% in the past month, which is instilling shareholder confidence that shares will continue to appreciate. The live chart on GLAXOSMITH for the past year to date showed a weekly increase of 8.33%, a monthly increase of 7.44%, a three-monthly increase of 5.69%, and a yearly increase of 12.1%.


Highlights of GlaxoSmithKline Consumer Nigeria Plc in 2022

Glaxo Smithkline Consumer Nigeria Plc started the year with a share price of 6.90 NGN, but it has since lost 5.8% from this price valuation, which has ranked the company 120th on the Nigerian Stock Exchange according to the year-to-date performance.

Shareholders’ fears are currently allayed by the 7% increase in the GLAXOSMITH price since mid-September, which has ranked the share 34th best on NGX. Glaxo Smithkline Consumer Nig. Plc is currently the 75th most-traded stock on the Nigerian Stock Exchange.

During the past three months, GLAXOSMITH experienced a trading volume of 16.4 million shares which were closed in 1,165 deals, with a total value of 100 million NGN during this period. There was an average of 260,945 shares traded per session. GLAXOSMITH experienced a trading volume high of 2.01 million shares on September 20th, with an all-time low of 11,441 recorded for mid-August.

During the past ten days, GLAXOSMITH experienced trading volumes ranging from between 40,391 and 635,659.

During the past quarter, Glaxo Smithkline Consumer Nigeria Plc reported double its revenue, which was up from 3,461 million NGN to 6,400 million NGN. Gross profits were also up from 1,037 million NGN for the first quarter, to 1,737 million NGN for the second quarter, indicating clear improvements.

There were also further improvements in the operating income, net income before and after taxes, and the overall diluted EPS excluding ExtraOrd items and the diluted normalized EPS, ensuring that shareholders receive solid dividends and return on their investment.

 

How to buy GlaxoSmithKline Consumer Nigeria Plc stocks Step-by-step

The stock market is one of the most attractive financial markets that sees millions of retail investors and traders’ participation daily. To buy, sell or trade GLAXOSMITH stocks, traders and investors can follow these simple steps:

  1. Find the share that you want to purchase, in this case, “GLAXOSMITH”.
  2. Select a forex broker that offers access to the Nigerian Stock Exchange (NGX).
  3. Review the broker’s trading conditions, fees, deposit and withdrawal methods, trading platform, customer support, regulation, and other components to ensure that they are aligned with your trading plan.
  4. Open a live trading account with the broker by completing the online application form and providing the necessary documentation to verify the trading account.
  5. Make your first share purchase through the broker.
  6. Build and diversify your portfolio by buying more shares.


FAQ

 

What type of company is GlaxoSmithKline Consumer Nigeria Plc?

Glaxo Smithkline Consumer Nigeria Plc is a Nigerian-based company involved with the manufacturing, marketing, and distribution of pharmaceutical, oral care, and nutritional products.

 

In which industry and sector does GlaxoSmithKline Consumer Nigeria Plc operate?

Glaxo Smithkline Consumer Nigeria Plc forms part of the Biotechnology and Drugs Industry, the Healthcare Sector, and Pharmaceuticals subsector.

 

On which stock exchange does GlaxoSmithKline Consumer Nigeria Plc have shares for sale?

Glaxo Smithkline Consumer Nigeria Plc trades its equity on the Nigerian Stock Exchange (NGX) under the stock symbol GLAXOSMITH.

 

What is the price of GLAXOSMITH shares today?

The current price of GLAXOSMITH shares is 6.50 NGN .

 

Is GlaxoSmithKline Consumer Nigeria Plc a good investment?

Yes, Glaxo Smithkline Consumer Nigeria Plc is a good investment, especially considering strong share financial performance in the past qu

 

 

Author Details

Louis Schoeman

Louis Schoeman

Featured Forex and Stocks writer

Table of Contents

You might also like

FINEXO Review

Overall, FINEXO is regulated by two tier-1 regulators, two tier-2 regulators, and four tier-3 regulators respectively. It has a high trust score of 97 out

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x